← FDA Drug Approvals (Drugs@FDA)

SILDENAFIL CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2012-11-06

Drug application

FDA Application #

ANDA202503

Application type

Abbreviated New Drug Application (Generic)

Brand name

SILDENAFIL CITRATE

Generic name

Sildenafil Citrate

Active ingredients

SILDENAFIL CITRATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

WATSON LABS INC

First approval

2012-11-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown